Indian Furosemide Exporters: Complete Supplier Ranking with Market Share — 778 Manufacturers (2026) — TransData Nexus

Q: Who is the largest furosemide buyer importing from India?

BAXTER HEALTHCARE CORPORATION (UNITED STATES) is the largest furosemide importer from India with a 20.5% market share and import value of $14.4M.

Q: How many furosemide buyers import from India?

There are 778 active furosemide buyers importing from India, with a combined import market of $70.5M across 4,657 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top furosemide buyers from India?

The top 5 furosemide buyers — BAXTER HEALTHCARE CORPORATION, RISING PHARMA HOLDINGS, INC., RISING PHARMA HOLDINGS INC, RISING PHARMA HOLDINGS INC,.,, SALUTAS PHARMA GMBH — together control 43.2% of total furosemide import value from India.

Suresh Sormare

Furosemide

India Pharmaceutical Trade Intelligence

$70.5M333 Suppliers150 CountriesHS 30049099

ExportsIndia → UNITED STATES60.2%India → CANADA7.3%

ImportsCANADA → India$79.8K GERMANY → India$43.9K

#1 Supplier: BAXTER PHARMACEUTICALS #1 Buyer: BAXTER HEALTHCARE

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $42.5M through 1,889 shipments. This represents a market share of 60.2% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• BAXTER HEALTHCARE CORPORATION - $14.4M (34.0% of country's total business)

• RISING PHARMA HOLDINGS, INC. - $6.3M (14.7% of country's total business)

• RISING PHARMA HOLDINGS INC - $4.2M (9.8% of country's total business)

• RISING PHARMA HOLDINGS INC,., - $3.6M (8.4% of country's total business)

• HOSPIRA INC - $1.9M (4.4% of country's total business)

• Rest of United States's importers - $12.2M (28.7% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $22.5K, indicating premium pricing strategy compared to the market average of $15.1K.

United States is a key market for Furosemide imports, representing 60.2% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Furosemide buyer market intelligence

1Buyer Segment Analysis

The importers of Furosemide from India can be categorized into several key segments:

1. Distributors: These entities purchase large quantities of Furosemide to supply to various healthcare providers, pharmacies, and retailers. Their buying behavior is characterized by bulk orders and a focus on cost-effectiveness. Notable distributors among the top buyers include:

BAXTER HEALTHCARE CORPORATION (UNITED STATES): $14.43M

RISING PHARMA HOLDINGS, INC. (UNITED STATES): $6.25M

RISING PHARMA HOLDINGS INC (UNITED STATES): $4.17M

RISING PHARMA HOLDINGS INC,., (UNITED STATES): $3.56M

HOSPIRA INC (UNITED STATES): $1.88M

AVET PHARMACEUTICALS INC. (UNITED STATES): $1.47M

ATHENEX PHARMACEUTICAL DIVISION (UNITED STATES): $1.30M

Country-Specific Import Regulations

TransData Nexus Furosemide buyer market intelligence

1Country-Specific Import Regulations

Understanding the import regulations for Furosemide in the top importing countries is crucial for market entry and compliance. Below is an overview for each country:

1. United States

Regulatory Authority: U.S. Food and Drug Administration (FDA)

Import Registration Process: Importers must ensure that Furosemide is approved by the FDA. This involves submitting an Abbreviated New Drug Application (ANDA) for generic drugs, demonstrating bioequivalence to the brand-name counterpart.

Estimated Timeline for Registration: The ANDA review process typically takes 10 months, though it can vary based on the completeness of the application and FDA workload.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in the United States.

2. Canada

Regulatory Authority: Health Canada

Demand Drivers & Market Opportunity

TransData Nexus Furosemide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Furosemide in importing countries is driven by several factors:

1. Disease Prevalence: Furosemide is primarily used to treat conditions such as congestive heart failure, liver cirrhosis, and renal impairment. The prevalence of these conditions, particularly in aging populations, contributes to sustained demand.

2. Government Healthcare Programs: Many countries have national health programs that subsidize essential medications, including Furosemide, ensuring widespread accessibility.

3. Universal Health Coverage Expansion: Efforts to expand health coverage increase the patient base eligible for treatment with Furosemide, thereby boosting demand.

4. WHO Essential Medicines List Procurement: Furosemide's inclusion in the World Health Organization's Essential Medicines List encourages its procurement by various health organizations and governments.

5. Tender-Based Purchasing: Many countries procure pharmaceuticals through tender systems, leading to bulk purchases of Furosemide to meet public health needs.

With 778 buyers across 150 countries, the global reach and consistent demand for Furosemide underscore its critical role in managing cardiovascular and renal conditions worldwide.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Furosemide Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest furosemide buyer importing from India?

Based on import volume and value, BAXTER HEALTHCARE CORPORATION (UNITED STATES) leads with $14.4M in imports and a 20.5% market share — the highest of any single furosemide importer. RISING PHARMA HOLDINGS, INC. (UNITED STATES) and RISING PHARMA HOLDINGS INC (UNITED STATES) are the next largest buyers.

QHow many companies buy furosemide from India?

There are 778 active furosemide buyers importing from India, with a combined market of $70.5M across 4,657 shipments to 150 countries. The top 5 buyers hold 43.2% of total import value, while the remaining 773 buyers handle the other 56.8%.

QWhich countries import the most furosemide from India?

The top importing countries for furosemide from India are United States (60.2%), Canada (7.3%), France (6.2%), Germany (2.9%), South Africa (2.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of furosemide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for furosemide from India?

The average import transaction value for furosemide from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Furosemide buyer market intelligence

1Buyer Segment Analysis

The importers of Furosemide from India can be categorized into several key segments:

BAXTER HEALTHCARE CORPORATION (UNITED STATES): $14.43M

RISING PHARMA HOLDINGS, INC. (UNITED STATES): $6.25M

RISING PHARMA HOLDINGS INC (UNITED STATES): $4.17M

RISING PHARMA HOLDINGS INC,., (UNITED STATES): $3.56M

HOSPIRA INC (UNITED STATES): $1.88M

AVET PHARMACEUTICALS INC. (UNITED STATES): $1.47M

ATHENEX PHARMACEUTICAL DIVISION (UNITED STATES): $1.30M

Country-Specific Import Regulations

TransData Nexus Furosemide buyer market intelligence

1Country-Specific Import Regulations

Understanding the import regulations for Furosemide in the top importing countries is crucial for market entry and compliance. Below is an overview for each country:

1. United States

Regulatory Authority: U.S. Food and Drug Administration (FDA)

Estimated Timeline for Registration: The ANDA review process typically takes 10 months, though it can vary based on the completeness of the application and FDA workload.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in the United States.

2. Canada

Regulatory Authority: Health Canada

Demand Drivers & Market Opportunity

TransData Nexus Furosemide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Furosemide in importing countries is driven by several factors:

2. Government Healthcare Programs: Many countries have national health programs that subsidize essential medications, including Furosemide, ensuring widespread accessibility.

3. Universal Health Coverage Expansion: Efforts to expand health coverage increase the patient base eligible for treatment with Furosemide, thereby boosting demand.

5. Tender-Based Purchasing: Many countries procure pharmaceuticals through tender systems, leading to bulk purchases of Furosemide to meet public health needs.

With 778 buyers across 150 countries, the global reach and consistent demand for Furosemide underscore its critical role in managing cardiovascular and renal conditions worldwide.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Furosemide

Furosemide

Who Buys Furosemide from India — 778 Importers Behind a $70.5M Market

Top Furosemide Importers — Ranked by Import Value

Top Furosemide Buyers & Importers

Related Analysis

Need Details?

Furosemide — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Furosemide — and from which countries?

Furosemide — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Furosemide Buyers & Importers

QWho is the largest furosemide buyer importing from India?

QHow many companies buy furosemide from India?

QWhich countries import the most furosemide from India?

QWhat is the average import order value for furosemide from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Canada

3France

4Germany

5South Africa

Analysis Methodology